| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 5,821 | 5,939 | 25,143 | 35,626 | | Cost of Revenue | 1,418 | 3,727 | 26,652 |
-
| | | Gross Profit | 4,403 | 2,212 | (1,509) | 35,626 | | | Operating Expenses | | Research Development | (2,037) | 2,037 |
-
|
-
| | Selling General and Administrative | 8,955 | 4,562 | (14,212) | 15,429 | | Non Recurring | 151 |
-
| 17,675 |
-
| | Others | 6,088 | 3,255 | 7,226 | 10,490 | | | | Total Operating Expenses | 13,157 |
-
|
-
|
-
| | | | Operating Income or Loss | (8,754) | (7,642) | (12,198) | 9,707 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,260) | (146) |
-
| 15,508 | | Earnings Before Interest And Taxes | (10,014) | (7,788) | (12,198) | 12,014 | | Interest Expense | 76 | 259 | 329 | 463 | | Income Before Tax | (10,090) | (8,047) | (12,527) | 11,551 | | Income Tax Expense | (639) | 1,645 | 1,453 | 1,489 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,451) | (9,692) | (13,980) | 23,263 | | | Non-recurring Events | | Discontinued Operations | 1,617 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,834) | (9,692) | (13,980) | 23,263 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,834) | ($9,692) | ($13,980) | $23,263 |
|
0.17% Nasdaq 
0.03 (1.21%) 
Income Statement
